Physician

James A Arcoleo, DO

According to 2025 Medicare claims, James Arcoleo, DO (NPI: 1407885676) practices cardiology in the Amherst Town-Northampton, MA market, with the plurality of this provider's patient population coming from Hampshire, MA. This provider's primary affiliated billing organization is MASS GENERAL BRIGHAM MEDICAL GROUP WESTERN MASSACHUSETTS INC (NPI: 1295787919; TIN: 043194547) and primary practice location at 01103-1979. Arcoleo is affiliated with the HARTFORD HEALTHCARE ACCOUNTABLE CARE ORGANIZATION, INC. (ACO ID: A1749), Mass General Brigham ACO, LLC (ACO ID: A4641), and Pioneer Valley Accountable Care, LLC (ACO ID: A5040), participating under the MSSP model.

Arcoleo's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 8,861 traditional Medicare patients, billed 20,879 HCPCS/CPT codes, and received $901,611 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 7,195 prescription claims across 1,406 beneficiaries totaling $2,100,535 in drug costs, led by Eliquis (Apixaban). 2019 DME data shows 11 claims. Open Payments data shows 96 records totaling $2,731. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $386,635 to $901,611. Similarly, Part D prescription costs have moved sharply higher in recent years, from $182,836 to $2,100,535. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,314	3,494	$386,635
2016	1,636	4,849	$558,034
2017	1,407	3,802	$418,521
2018	2,089	5,262	$582,111
2019	1,804	5,226	$586,110
2020	2,956	6,082	$469,566
2021	5,099	9,754	$566,211
2022	9,146	19,803	$753,910
2023	9,629	20,024	$651,720
2024	8,861	20,879	$901,611

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	526	2,875	$182,836
2016	726	4,171	$265,391
2017	774	5,122	$453,694
2018	829	5,779	$625,594
2019	885	5,686	$783,899
2020	909	5,716	$934,648
2021	1,026	5,837	$1,163,777
2022	1,000	5,484	$1,312,309
2023	1,158	5,964	$1,553,788
2024	1,406	7,195	$2,100,535

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	24	$1,421
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	11	$627
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	1,632	2,119	$103
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	940	1,326	$93
93294	Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days	449	1,407	$21
93296	Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days	562	1,537	$16
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	6,155	9,518	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	694	50,291	$938,416
Xarelto	Rivaroxaban	295	21,260	$380,782
Entresto	Sacubitril/Valsartan	181	11,922	$259,860
Repatha Sureclick	Evolocumab	145	7,797	$147,935
Praluent Pen	Alirocumab	50	3,206	$55,022

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	96	$2,731	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for James A. Arcoleo, DO?

Tedicare shows public-source Medicare data for James A. Arcoleo, DO (NPI 1407885676), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James A. Arcoleo, DO have ACO affiliation data?

James A. Arcoleo, DO is shown with ACO affiliation data for HARTFORD HEALTHCARE ACCOUNTABLE CARE ORGANIZATION, INC. (MSSP, ACO ID A1749), Mass General Brigham ACO, LLC (MSSP, ACO ID A4641), and Pioneer Valley Accountable Care, LLC (MSSP, ACO ID A5040).

What billing organization is linked to James A. Arcoleo, DO?

James A. Arcoleo, DO is linked to MASS GENERAL BRIGHAM MEDICAL GROUP WESTERN MASSACHUSETTS INC (billing NPI 1295787919) in the available physician profile data.

Does James A. Arcoleo, DO have Open Payments data?

James A. Arcoleo, DO has 96 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.